On August 31, 2023 Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") reported that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the following investor conferences (Press release, Halozyme, AUG 31, 2023, View Source [SID1234634810]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details on the presentations are as follow:
Event:
2023 Wells Fargo Healthcare Conference
Format:
Fireside Chat and 1×1 Meetings
Presentation Date:
Thursday, September 7, 2023
Presentation Time:
8:00 a.m. ET / 5:00 a.m. PT
Location:
Boston, MA
Event:
H.C. Wainwright 25th Annual Global Investment Conference
Format:
Fireside Chat and 1×1 Meetings
Presentation Date:
Monday, September 11, 2023
Presentation Time:
9:30 a.m. ET / 6:30 a.m. PT
Location:
New York, NY
Event:
Morgan Stanley 21st Annual Global Healthcare Conference
Format:
Fireside Chat and 1×1 Meetings
Presentation Date:
Tuesday, September 12, 2023
Presentation Time:
10:50 a.m. ET / 7:50 a.m. PT
Location:
New York, NY
Event:
Baird 2023 Global Healthcare Conference
Format:
Fireside Chat and 1×1 Meetings
Presentation Date:
Wednesday, September 13, 2023
Presentation Time:
1:25 p.m. ET / 10:25 a.m. PT
Location:
New York, NY
A live audio webcast of the Wells Fargo, H.C. Wainwright and Morgan Stanley presentations will be available in the Investor Relations section of the Company’s website. Replays of the audio webcasts will be available for 90 days following the conference.